News & Updates

ICI therapy safe to use in aggressive pituitary neuroendocrine tumours

Treatment with immune checkpoint inhibitors (ICI) is safe and feasible in patients with aggressive pituitary neuroendocrine tumours (PNTs), a recent study has shown.

Carnosine: The Multi-Target Agent in Neuroprotection

NAFLD/MAFLD carries increased risk of nephrolithiasis

Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction–associated fatty liver disease (MAFLD) have an elevated risk of nephrolithiasis, according to a study.

Oseltamivir can keep children with flu out of the ICU

Treatment with oseltamivir in children hospitalized with influenza helps prevent progression into a state requiring ICU admission and shorten the length of hospital stay, as shown in a US-based retrospective study.

SGLT2 inhibitors help prevent anaemia in patients with diabetes

The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors resulted in a reduced prevalence of anaemia and decreased risk of hospitalizations due to anaemia relative to the use of dipeptidyl peptidase 4 (DPP4) inhibitors in patients with diabetes, reports a study.

Impostor phenomenon common among young professionals in SG

Impostor phenomenon (IP) appears to be prevalent among individuals aged 21‒29 years, according to a Singapore study involving employees in the National University Health System (NUHS).

CGM improves glycaemic excursion detection in T2D patients on haemodialysis

Continuous glucose monitoring (CGM) among individuals with type 2 diabetes (T2D) and end-stage kidney disease (ESKD) on haemodialysis helps enhance the detection of hyperglycaemic and hypoglycaemic events, particularly nocturnal and prolonged episodes, suggests a study.

Obesity, physical activity influence subsequent neoplasm risk in childhood cancer survivors

Obesity contributes to an increased risk of multiple subsequent neoplasms in childhood cancer survivors, but higher physical activity confers a protective effect, according to a retrospective study.

Prior herpes zoster vaccination mitigates long-term complications after infection

For individuals who sustained herpes zoster infection, prior receipt of recombinant zoster vaccine appears to reduce the long-term risks of major adverse cardiovascular events, dementia, and death, according to a retrospective study.

Radiotherapy vs imiquimod: Which is a better nonsurgical option for lentigo maligna?

Radiotherapy and imiquimod are both efficacious and well-tolerated in patients with complex lentigo maligna who are not suitable for surgery, with no negative effects on health-related quality of life (HRQoL) at 24 months, reports a study.